Literature DB >> 23782779

[Comparison of dose calculation algorithms in stereotactic radiation therapy in lung].

Yuki Tomiyama1, Fujio Araki, Nagisa Kanetake, Yoshinobu Shimohigashi, Hirofumi Tominaga, Jyunichi Sakata, Takeshi Oono, Tomohiro Kouno, Kazunari Hioki.   

Abstract

Dose calculation algorithms in radiation treatment planning systems (RTPSs) play a crucial role in stereotactic body radiation therapy (SBRT) in the lung with heterogeneous media. This study investigated the performance and accuracy of dose calculation for three algorithms: analytical anisotropic algorithm (AAA), pencil beam convolution (PBC) and Acuros XB (AXB) in Eclipse (Varian Medical Systems), by comparison against the Voxel Monte Carlo algorithm (VMC) in iPlan (BrainLab). The dose calculations were performed with clinical lung treatments under identical planning conditions, and the dose distributions and the dose volume histogram (DVH) were compared among algorithms. AAA underestimated the dose in the planning target volume (PTV) compared to VMC and AXB in most clinical plans. In contrast, PBC overestimated the PTV dose. AXB tended to slightly overestimate the PTV dose compared to VMC but the discrepancy was within 3%. The discrepancy in the PTV dose between VMC and AXB appears to be due to differences in physical material assignments, material voxelization methods, and an energy cut-off for electron interactions. The dose distributions in lung treatments varied significantly according to the calculation accuracy of the algorithms. VMC and AXB are better algorithms than AAA for SBRT.

Entities:  

Mesh:

Year:  2013        PMID: 23782779     DOI: 10.6009/jjrt.2013_jsrt_69.6.663

Source DB:  PubMed          Journal:  Nihon Hoshasen Gijutsu Gakkai Zasshi        ISSN: 0369-4305


  1 in total

1.  Clinical implications of Eclipse analytical anisotropic algorithm and Acuros XB algorithm for the treatment of lung cancer.

Authors:  Gangarapu Sri Krishna; Vuppu Srinivas; Palreddy Yadagiri Reddy
Journal:  J Med Phys       Date:  2016 Oct-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.